高敏心肌肌钙蛋白与卒中风险的荟萃分析
在一般人群中,高 versus 低hs-cTn的汇总调整风险比为1.25(95%CI 1.10-1.40);在房颤患者中为1.95(95%CI 1.29-2.62)。结论认为hs-cTn可作为 incident 卒中的风险标志物,但不同亚组效应量不同。
要点
- 一般人群中高hs-cTn与卒中风险增加相关,汇总调整HR为1.25(95%CI 1.10-1.40)。
- 房颤患者中高hs-cTn的卒中风险关联更强,汇总调整HR为1.95(95%CI 1.29-2.62)。
- 既往卒中患者数据不足,仅1项研究197人,无法进行荟萃分析。
核心结论
- hs-cTn可被视为 incident 卒中的风险标志物,不同亚组效应量不同。
- 需要更多研究探讨高危人群(尤其缺血性卒中病史者)中hs-cTn与 incident 卒中的关联。
研究设计与样本
- 系统检索Embase、PubMed和Web of Science至2019年3月14日,纳入随机对照试验和队列研究。
- 采用随机效应模型计算汇总调整风险比(HR)及95%CI。
主要发现
- 一般人群中,高 versus 低hs-cTn的 incident 卒中汇总调整HR为1.25(95%CI 1.10-1.40),平均随访1至20年(中位10年)。
- 使用分类数据时,一般人群汇总调整HR增至1.58(95%CI 1.26-1.90)。
- 房颤患者中,高 versus 低hs-cTn的 incident 卒中汇总调整HR为1.95(95%CI 1.29-2.62)。
- 结果在考虑卒中分类(全因/缺血性)、hs-cTn亚基、偏倚风险及hs-cTn编码方式后仍稳健。
- 既往卒中患者因数据不足(1项研究197人)未进行荟萃分析。
关键数值与推荐
- 一般人群高 versus 低hs-cTn:汇总调整HR 1.25(95%CI 1.10-1.40)。
- 一般人群分类数据:汇总调整HR 1.58(95%CI 1.26-1.90)。
- 房颤患者高 versus 低hs-cTn:汇总调整HR 1.95(95%CI 1.29-2.62)。
临床怎么用
- 在一般人群和房颤患者中,hs-cTn升高可提示 incident 卒中风险增加,可作为风险分层参考。
- 对既往卒中患者,目前证据不足以支持常规使用hs-cTn预测卒中复发风险。
局限性
- 研究间存在异质性,采用随机效应模型合并。
- 既往卒中患者数据缺乏,仅1项研究197人,无法进行荟萃分析。
- hs-cTn高低定义因纳入研究而异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Our study aim was to estimate risk of incident stroke based on levels of hs-cTn (high-sensitivity cardiac troponin), a specific biomarker indicating myocardial injury, in the general population, patients with atrial fibrillation, and patients with previous stroke. Methods- Embase, PubMed, and Web of Science were searched until March 14, 2019 to identify relevant articles. Randomized controlled trials and cohort studies assessing the risk of incident stroke based on hs-cTn were eligible. Pooled adjusted hazard ratios including 95% CI were calculated using a random-effects model due to study heterogeneity per population, coding of hs-cTn (categorical/continuous data), per hs-cTn subunit (T or I), for low risk of bias, and for all-cause and ischemic stroke separately. Results- We included 17 articles with 96 702 participants. In studies conducted in the general population (n=12; 77 780 participants), the pooled adjusted hazard ratio for incident stroke was 1.25 (CI, 1.10-1.40) for high versus low hs-cTn (as defined by included studies) during an average follow-up of 1 to 20 years (median 10). When categorical data were used, this was increased to 1.58 (CI, 1.26-1.90). The results were robust when accounting for stroke classification (all-cause stroke/ischemic stroke), hs-cTn subunit, risk of bias, and coding of hs-cTn. In patients with atrial fibrillation (4 studies; 18 725 participants), the pooled adjusted hazard ratio for incident stroke was 1.95 (CI, 1.29-2.62) for high versus low hs-cTn. Due to lack of data (one study, 197 participants), no meta-analysis could be performed in patients with previous stroke. Conclusions- This meta-analysis suggests that hs-cTn can be regarded as a risk marker for incident stroke, with different effect size in different subgroups. More research about the association between hs-cTn and incident stroke in high-risk populations is needed, especially in patients with history of ischemic stroke.
引用
- Broersen LHA, Stengl H, Nolte CH, et al. Association Between High-Sensitivity Cardiac Troponin and Risk of Stroke in 96 702 Individuals: A Meta-Analysis. Stroke. 2020. PMID: 32078461. doi:10.1161/STROKEAHA.119.028323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。